Evidence map›Paper›PMID 20864668›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2010

Nuclear factor {kappa}B-mediated transactivation of telomerase prevents intimal smooth muscle cell from replicative senescence during vascular repair.

De-xiu Bu, Maria E Johansson, Jingyi Ren, Da-wei Xu, F Brad Johnson, Kristina Edfeldt, Zhong-qun Yan

Open access · greenAbstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

De-xiu BuCardiovascular Research Unit, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden. dbu@rics.bwh.harvard.edu
Maria E Johansson
Jingyi Ren
Da-wei Xu
F Brad Johnson
Kristina Edfeldt
Zhong-qun Yan
University of Pennsylvania · USKarolinska University Hospital · SE

Funding

Telomere maintenance by Werner syndrome family proteins.R01AG021521 · NIA · UNIVERSITY OF PENNSYLVANIA · PI JOHNSON, F. BRAD · 2004 to 2013
$2.8M
NIA NIH HHS R01 AG021521
6 · The paper itself

Abstract

objectiveTo gain insights into mechanisms by which intimal hyperplasia interferes with the repair process by investigating expression and function of the catalytic telomerase reverse transcriptase (TERT) subunit after vascular injury. METHODS AND

resultsFunctional telomerase is essential to the replicative longevity of vascular cells. We found that TERT was de novo activated in the intima of injured arteries, involving activation of the nuclear factor κB pathway. Stimulation of the isolated intimal smooth muscle cell (SMC) by basic fibroblast growth factor or tumor necrosis factor α resulted in increased TERT activity. This depends on the activation of c-Myc signaling because mutation of the E-box in the promoter or overexpression of mitotic arrest deficient 1 (MAD1), a c-Myc competitor, abrogated the transcriptional activity. Inhibition of nuclear factor κB in both intimal SMCs and the injured artery attenuated TERT transcriptional activity through reduction of c-Myc expression. Pharmacological blockade of TERT led to SMC senescence. Finally, depletion of telomerase function in mice resulted in severe intimal SMC senescence after vascular injury.

conclusionsThese results support a model in which vascular injury induces de novo expression of TERT in intimal SMCs via activation of nuclear factor κB and upregulation of c-Myc. The resumed TERT activity is critical for intimal hyperplasia.

Indexed as

Cell ProliferationCellular SenescenceTranscriptional ActivationAminobenzoatesAnimalsBinding SitesCarotid Artery InjuriesCells, CulturedDisease Models, AnimalEnzyme InhibitorsFibroblast Growth Factor 2Gene Expression Regulation, EnzymologicHyperplasiaI-kappa B KinaseMaleMiceAminobenzoatesBIBR 1532Enzyme InhibitorsFibroblast Growth Factor 2I-kappa B KinaseNaphthalenesNF-kappa BProto-Oncogene Proteins c-mycRNARNA, MessengerTelomerasetelomerase RNATert protein, mouseTumor Necrosis Factor-alpha

Identifiers

PMID20864668
PMCPMC2988113
OpenAlexW2093272955

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.